Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease[S]

Article, Other literature type English OPEN
Reis, Ana ; Rudnitskaya, Alisa ; Chariyavilaskul, Pajaree ; Dhaun, Neeraj ; Melville, Vanessa ; Goddard, Jane ; Webb, David J. ; Pitt, Andrew R. ; Spickett, Corinne M. (2015)
  • Publisher: The American Society for Biochemistry and Molecular Biology
  • Related identifiers: doi: 10.1194/jlr.M055624
  • Subject: inflammation | partial least squares discriminant analysis | cholesterol | mass spectrometry | N-acyltaurine | dyslipidemias | phospholipids | Research Articles | cholesterol sulfate
    mesheuropmc: lipids (amino acids, peptides, and proteins)

This study compared the molecular lipidomic profi le of LDL in patients with nondiabetic advanced renal disease and no evidence of CVD to that of age-matched controls, with the hypothesis that it would reveal proatherogenic lipid alterations. LDL was isolated from 10 normocholesterolemic patients with stage 4/5 renal disease and 10 controls, and lipids were analyzed by accurate mass LC/MS. Top-down lipidomics analysis and manual examination of the data identifi ed 352 lipid species, and automated comparative analysis demonstrated alterations in lipid profi le in disease. The total lipid and cholesterol content was unchanged, but levels of triacylglycerides and N -acyltaurines were signifi cantly increased, while phosphatidylcholines, plasmenyl ethanolamines, sulfatides, ceramides, and cholesterol sulfate were signifi cantly decreased in chronic kidney disease (CKD) patients. Chemometric analysis of individual lipid species showed very good discrimination of control and disease sample despite the small cohorts and identifi ed individual unsaturated phospholipids and triglycerides mainly responsible for the discrimination. These fi ndings illustrate the point that although the clinical biochemistry parameters may not appear abnormal, there may be important underlying lipidomic changes that contribute to disease pathology. The lipidomic profi le of CKD LDL offers potential for new biomarkers and novel insights into lipid metabolism and cardiovascular risk in this disease. -Reis, A., A. Rudnitskaya, P. Chariyavilaskul, N. Dhaun, V. Melville, J. Goddard, D. J. Webb, A. R. Pitt, and C. M. Spickett. Topdown lipidomics of low density lipoprotein reveal altered lipid profi les in advanced chronic kidney disease. J. Lipid Res. 2015.
  • References (53)
    53 references, page 1 of 6

    1. Meguid El Nahas, A., and A. K. Bello. 2005. Chronic kidney disease: the global challenge. Lancet. 365: 331-340.

    2. Sarnak, M. J., A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. 2003. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 108: 2154-2169.

    3. Schiffrin, E. L., M. L. Lipman, and J. F. E. Mann. 2007. Chronic kidney disease: effects on the cardiovascular system. Circulation. 116: 85-97.

    4. Zoccali, C. 2006. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int. 70: 26-33.

    5. Steinberg, D. 2005. Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin. Mol. Nutr. Food Res. 49: 995-998.

    6. Shepherd, J. 2004. Lipids in health and disease. Biochem. Soc. Trans. 32: 1051-1056.

    7. Keane, W. F., J. E. Tomassini, and D. R. Neff. 2013. Lipid abnormalities in patients with chronic kidney disease: implications for the pathophysiology of atherosclerosis. J. Atheroscler. Thromb. 20: 123-133.

    8. Cheung, A. K. 2009. Is lipid control necessary in hemodialysis patients? Clin. J. Am. Soc. Nephrol. 4: S95-S101.

    9. Kaysen, G. A. 2009. Lipid and lipoprotein metabolism in chronic kidney disease. J. Ren. Nutr. 19: 73-77.

    10. Vaziri, N. D., and K. Norris. 2011. Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purif. 31: 189-196.

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark